Tipo de documento: info:eu-repo/semantics/other
DOI: 10.1371/journal.pone.0044971.t001
Publicaciones relacionadas: Guasch, L., Ojeda, M. J., González-Abuín, N., Sala, E., Cereto-Massagué, A., Mulero, M., Valls, C., Pinent, M., Ardévol, A., Garcia-Vallvé, S., & Pujadas, G. (2012). Identification of novel human dipeptidyl peptidase-iv inhibitors of natural origin (Part i): Virtual screening and activity assays. PLoS ONE, 7(9), e44971. https://doi.org/10.1371/journal.pone.0044971
Grupo de investigación: Nutrigenòmica
Departamento: Bioquímica i Biotecnologia
Autor: Guasch, Laura
Fecha alta repositorio: 2012-09-12
Año de publicación de la dataset: 2012
Materia: Bioquímica
Identificador del investigador: 0000-0003-4990-7765
DOI de la publicación relacionada: 10.1371/journal.pone.0044971
Idioma: en
Publicado por (editorial): Universitat Rovira i Virgili (URV)
Derechos de acceso: info:eu-repo/semantics/openAccess
Resumen: Some PDB structures were discarded for the following reasons: (a) the structures were of apo forms without inhibitor, (b) inhibitors were covalently linked with Ser630, (c) inhibitors were of oligopeptide nature, (d) there were no structural factors available in the PDB or (e) the scripts in the EDS failed to produce the map from the structural factors. PDB structures marked with an asterisk (*) have mutations in the enzyme to modify the activity. Only the PDB files from the “Valid PDB Structures” section with IC50 values ≤10 nM (in bold) were used to derive the corresponding structure-based common pharmacophore for DPP-IV inhibition (see Figure 1).
Repositori URV